Neurocirujano se sustenta en investigación para mejorar atención a pacientes
Neurosurgeon leans on research to improve patient care
Participants of pioneering CRISPR gene editing trial see vision improve
Participantes del ensayo pionero de edición génica CRISPR experimentan mejoras en la vista
Phil Knight
Nike, Inc. co-founder Phil Knight accepts the AACI "Champions for Cures" award via a video message (Phil Knight).
Brian Druker, M.D.
Brian Druker, M.D., presents the 2020 AACI "Champions for Cures" award to Phil and Penny Knight via a video message. (OHSU/Brian Druker)
The Knights and Brian Druker
Nike, Inc. co-founder Phil Knight and his wife, Penny, with OHSU Knight Cancer Institute Director Brian Druker, M.D. The Knights received the 2020 "Champions for Cures" award from the Association of American Cancer Institutes. (OHSU Foundation)
Knight Cancer Institute Research
The Knight Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center between Sacramento and Seattle — an honor earned only by the nation's top cancer centers. It offers the latest treatments and technologies as well as hundreds of research studies and clinical trials. (OHSU/Christine Torres Hicks)